Skip to content

Icagen, Inc.

CIK 0001518520

← back to feed
Revenue (TTM)
$13.97M
−40.0% YoY Q3 Feb 2020
Net Income (TTM)
−$13.1M
−113.4% YoY Q3 Feb 2020
EPS Diluted (TTM)
−$1.99
Q3 Feb 2020
Gross Margin
32.3%
Q3 Feb 2020
Operating Margin
-53.6%
Q3 Feb 2020
Net Margin
-93.8%
Q3 Feb 2020
Free Cash Flow (TTM)
−$8.5M
Q3 Feb 2020
Cash
$2.15M
Q3 Feb 2020
Total Debt
$8.15M
Q3 Feb 2020
Shares Outstanding
6.39M sh
Q3 Feb 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings